Our Products

Erlotinib Tablets IP 100 mg is a targeted therapy used primarily for the treatment of non-small cell lung cancer (NSCLC) and pancreatic cancer. It works by inhibiting the epidermal growth factor receptor (EGFR) tyrosine kinase, which is involved in the growth and spread of cancer cells. By blocking EGFR, Erlotinib helps to slow down or stop cancer cell proliferation. The typical dose is 100 mg, usually taken once daily, with or without food. Common side effects may include rash, diarrhea, nausea, and fatigue. It is important for patients to be monitored for potential side effects during treatment.